David Fenyö has become a staff scientist at Amersham Biosciences, joining the company in January. Prior to that, he was director of proteomics at Ann Arbor, Mich.-based Genomic Solutions. He joined Genomic Solutions in 2002 after it acquired the technology of ProteoMetrics of New York, which Fenyö co-founded and where he served as president. He holds a PhD in physics from Uppsala University in Sweden.
David Feny, Michael Washburn, John Yates, Tim Sutton, David Campbell, RJ Twilegar, Tim Burland
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.